Tag: Cochrane risk of bias
My story is not just about the personal costs of speaking truth to power. This is a story about institutional corruption and one of the worst show trials in academia that you can imagine. I have written a book that documents the truth, backed by leaked board room recordings, private emails and testimony from concerned citizens.
Scientific freedom and integrity are constantly under attack, particularly in healthcare, which is dominated by the drug industry and other economic interests. To help preserve honesty and integrity in science, the new Institute for Scientific Freedom will open on March 9 with an international meeting in Copenhagen.
I am just the messenger, the symbol that healthcare is in many ways absurd and harmful because the drug industry is too powerful. The Cochrane Collaboration is in deep crisis because it is too close to industry, practices scientific censorship and has a business model that focuses on “brand” and “our product” rather than getting the science right.
In a large review study published this week in The Lancet, researchers assessed the effectiveness and potential harms of fourteen different antidepressants for their use in children and adolescents. The negative results, familiar to MIA readers, are now making major headlines.